Correlations (r) between disease activity and metabolic and cardiovascular risks of patients
| Parameters | BASDAI | PASI | DAPSA | BASFI | HAQ | VAI | SCORE | Framingham risk score |
|---|---|---|---|---|---|---|---|---|
| Framingham risk score | 0.02 | 0.095 | 0.285** | 0.202** | 0.067 | 0.299** | 0.523 | 1 |
| SCORE | -0.079 | -0.026 | 0.095 | 0.065 | -0.01 | 0.058 | 1 | 0.523** |
| VAI | 0.128 | 0.192 | 0.101 | 0.105 | 0.019 | 1 | 0.058 | 0.299** |
| HAQ | 0.129 | 0.135 | 0.421** | 0.284** | 1 | 0.019 | -0.01 | 0.067 |
| BASFI | 0.764** | 0.14 | 0.484** | 1 | 0.284** | 0.105 | 0.065 | 0.202* |
| DAPSA | 0.462** | 0.341** | 1 | 0.484** | 0.421** | 0.101 | 0.095 | 0.285** |
| PASI | 0.092 | 1 | 0.341** | 0.140 | 0.135 | 0.192 | -0.026 | 0.095 |
| BASDAI | 1 | 0.092 | 0.462** | 0.764** | 0.129 | 0.128 | -0.079 | 0.024 |
Abbreviation; VAI: Visceral Adiposity Index, SCORE: Systematic Coronary Risk Evaluation Index, Health Assessment Questionnaire (HAQ), Disease Activity Index for Psoriatic Arthritis (DAPSA), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Disease Activity Index (BASFI) and Psoriasis Area Severity Index (PASI). *p<0.05, **p<0.001